カテゴリー： GlobalInfoResearch, 世界

婦人科薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Gynecology Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9103384）・商品コード：GIR9103384
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月26日（※2024年版があります。お問い合わせください）
・ページ数：136
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、婦人科薬の世界市場について調べ、まとめました。種類別セグメントは、ホルモン療法、非ホルモン療法等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。婦人科薬の世界市場概観、企業動向、企業別婦人科薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・婦人科薬の市場概観
・婦人科薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・婦人科薬の企業別販売動向、市場シェア、市場集中度、競争動向
・婦人科薬の世界市場規模
・婦人科薬の北米市場分析（アメリカ、カナダ、メキシコ等）
・婦人科薬のアメリカ市場規模推移
・婦人科薬のカナダ市場規模推移
・婦人科薬のメキシコ市場規模推移
・婦人科薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・婦人科薬のドイツ市場規模推移
・婦人科薬のイギリス市場規模推移
・婦人科薬のロシア市場規模推移
・婦人科薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・婦人科薬の日本市場規模推移
・婦人科薬の中国市場規模推移
・婦人科薬の韓国市場規模推移
・婦人科薬のインド市場規模推移
・婦人科薬の東南アジア市場規模推移
・婦人科薬の南米市場分析（ブラジル、アルゼンチン等）
・婦人科薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・婦人科薬の種類別分析/販売量、売上、市場シェア（ホルモン療法、非ホルモン療法）
・婦人科薬の用途別分析/市場規模（病院薬局、小売薬局、オンライン薬局）
・婦人科薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・婦人科薬の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Scope of the Report:
The global Gynecology Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Gynecology Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Gynecology Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Gynecology Drugs market by product type and applications/end industries.

Market Segment by Companies, this report covers
Pfizer
Roche
AbbVie
Bayer
Merck
Abbott Laboratories
GlaxoSmithKline
Johnson & Johnson
Sanofi
Novartis
Eli Lilly
AstraZeneca
Allergan
Amgen
Chengdu Enwei Group

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Hormonal Therapy
Non-hormonal Therapy

Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

【レポートの目次】

Table of Contents

1 Gynecology Drugs Market Overview
1.1 Product Overview and Scope of Gynecology Drugs
1.2 Classification of Gynecology Drugs by Types
1.2.1 Global Gynecology Drugs Revenue Comparison by Types (2019-2024)
1.2.2 Global Gynecology Drugs Revenue Market Share by Types in 2018
1.2.3 Hormonal Therapy
1.2.4 Non-hormonal Therapy
1.3 Global Gynecology Drugs Market by Application
1.3.1 Global Gynecology Drugs Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Gynecology Drugs Market by Regions
1.4.1 Global Gynecology Drugs Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Gynecology Drugs Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Gynecology Drugs Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gynecology Drugs Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Gynecology Drugs Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gynecology Drugs Status and Prospect (2014-2024)
1.5 Global Market Size of Gynecology Drugs (2014-2024)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Gynecology Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Gynecology Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.2 Roche
2.2.1 Business Overview
2.2.2 Gynecology Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Roche Gynecology Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.3 AbbVie
2.3.1 Business Overview
2.3.2 Gynecology Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 AbbVie Gynecology Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.4 Bayer
2.4.1 Business Overview
2.4.2 Gynecology Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bayer Gynecology Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.5 Merck
2.5.1 Business Overview
2.5.2 Gynecology Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merck Gynecology Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.6 Abbott Laboratories
2.6.1 Business Overview
2.6.2 Gynecology Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Abbott Laboratories Gynecology Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.7 GlaxoSmithKline
2.7.1 Business Overview
2.7.2 Gynecology Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 GlaxoSmithKline Gynecology Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.8 Johnson & Johnson
2.8.1 Business Overview
2.8.2 Gynecology Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Johnson & Johnson Gynecology Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.9 Sanofi
2.9.1 Business Overview
2.9.2 Gynecology Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sanofi Gynecology Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.10 Novartis
2.10.1 Business Overview
2.10.2 Gynecology Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Novartis Gynecology Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.11 Eli Lilly
2.11.1 Business Overview
2.11.2 Gynecology Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Eli Lilly Gynecology Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.12 AstraZeneca
2.12.1 Business Overview
2.12.2 Gynecology Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 AstraZeneca Gynecology Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.13 Allergan
2.13.1 Business Overview
2.13.2 Gynecology Drugs Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Allergan Gynecology Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.14 Amgen
2.14.1 Business Overview
2.14.2 Gynecology Drugs Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Amgen Gynecology Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.15 Chengdu Enwei Group
2.15.1 Business Overview
2.15.2 Gynecology Drugs Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Chengdu Enwei Group Gynecology Drugs Revenue, Gross Margin and Market Share (2017-2018)
3 Global Gynecology Drugs Market Competition, by Players
3.1 Global Gynecology Drugs Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Gynecology Drugs Players Market Share
3.2.2 Top 10 Gynecology Drugs Players Market Share
3.3 Market Competition Trend
4 Global Gynecology Drugs Market Size by Regions
4.1 Global Gynecology Drugs Revenue and Market Share by Regions
4.2 North America Gynecology Drugs Revenue and Growth Rate (2014-2019)
4.3 Europe Gynecology Drugs Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Gynecology Drugs Revenue and Growth Rate (2014-2019)
4.5 South America Gynecology Drugs Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Gynecology Drugs Revenue and Growth Rate (2014-2019)
5 North America Gynecology Drugs Revenue by Countries
5.1 North America Gynecology Drugs Revenue by Countries (2014-2019)
5.2 USA Gynecology Drugs Revenue and Growth Rate (2014-2019)
5.3 Canada Gynecology Drugs Revenue and Growth Rate (2014-2019)
5.4 Mexico Gynecology Drugs Revenue and Growth Rate (2014-2019)
6 Europe Gynecology Drugs Revenue by Countries
6.1 Europe Gynecology Drugs Revenue by Countries (2014-2019)
6.2 Germany Gynecology Drugs Revenue and Growth Rate (2014-2019)
6.3 UK Gynecology Drugs Revenue and Growth Rate (2014-2019)
6.4 France Gynecology Drugs Revenue and Growth Rate (2014-2019)
6.5 Russia Gynecology Drugs Revenue and Growth Rate (2014-2019)
6.6 Italy Gynecology Drugs Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Gynecology Drugs Revenue by Countries
7.1 Asia-Pacific Gynecology Drugs Revenue by Countries (2014-2019)
7.2 China Gynecology Drugs Revenue and Growth Rate (2014-2019)
7.3 Japan Gynecology Drugs Revenue and Growth Rate (2014-2019)
7.4 Korea Gynecology Drugs Revenue and Growth Rate (2014-2019)
7.5 India Gynecology Drugs Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Gynecology Drugs Revenue and Growth Rate (2014-2019)
8 South America Gynecology Drugs Revenue by Countries
8.1 South America Gynecology Drugs Revenue by Countries (2014-2019)
8.2 Brazil Gynecology Drugs Revenue and Growth Rate (2014-2019)
8.3 Argentina Gynecology Drugs Revenue and Growth Rate (2014-2019)
8.4 Colombia Gynecology Drugs Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Gynecology Drugs by Countries
9.1 Middle East and Africa Gynecology Drugs Revenue by Countries (2014-2019)
9.2 Saudi Arabia Gynecology Drugs Revenue and Growth Rate (2014-2019)
9.3 UAE Gynecology Drugs Revenue and Growth Rate (2014-2019)
9.4 Egypt Gynecology Drugs Revenue and Growth Rate (2014-2019)
9.5 Nigeria Gynecology Drugs Revenue and Growth Rate (2014-2019)
9.6 South Africa Gynecology Drugs Revenue and Growth Rate (2014-2019)
10 Global Gynecology Drugs Market Segment by Type
10.1 Global Gynecology Drugs Revenue and Market Share by Type (2014-2019)
10.2 Global Gynecology Drugs Market Forecast by Type (2019-2024)
10.3 Hormonal Therapy Revenue Growth Rate (2014-2024)
10.4 Non-hormonal Therapy Revenue Growth Rate (2014-2024)
11 Global Gynecology Drugs Market Segment by Application
11.1 Global Gynecology Drugs Revenue Market Share by Application (2014-2019)
11.2 Gynecology Drugs Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2014-2019)
11.4 Retail Pharmacies Revenue Growth (2014-2019)
11.5 Online Pharmacies Revenue Growth (2014-2019)
12 Global Gynecology Drugs Market Size Forecast (2019-2024)
12.1 Global Gynecology Drugs Market Size Forecast (2019-2024)
12.2 Global Gynecology Drugs Market Forecast by Regions (2019-2024)
12.3 North America Gynecology Drugs Revenue Market Forecast (2019-2024)
12.4 Europe Gynecology Drugs Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Gynecology Drugs Revenue Market Forecast (2019-2024)
12.6 South America Gynecology Drugs Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Gynecology Drugs Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Gynecology Drugs Picture
Table Product Specifications of Gynecology Drugs
Table Global Gynecology Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Gynecology Drugs Revenue Market Share by Types in 2018
Figure Hormonal Therapy Picture
Figure Non-hormonal Therapy Picture
Table Global Gynecology Drugs Revenue (Million USD) by Application (2014-2024)
Figure Gynecology Drugs Revenue Market Share by Applications in 2018
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Online Pharmacies Picture
Table Global Market Gynecology Drugs Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Gynecology Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Gynecology Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Gynecology Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Gynecology Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Gynecology Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Gynecology Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Gynecology Drugs Type and Applications
Table Pfizer Gynecology Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Gynecology Drugs Type and Applications
Table Roche Gynecology Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Gynecology Drugs Type and Applications
Table AbbVie Gynecology Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Gynecology Drugs Type and Applications
Table Bayer Gynecology Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Gynecology Drugs Type and Applications
Table Merck Gynecology Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories Gynecology Drugs Type and Applications
Table Abbott Laboratories Gynecology Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Gynecology Drugs Type and Applications
Table GlaxoSmithKline Gynecology Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Gynecology Drugs Type and Applications
Table Johnson & Johnson Gynecology Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Gynecology Drugs Type and Applications
Table Sanofi Gynecology Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Gynecology Drugs Type and Applications
Table Novartis Gynecology Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Gynecology Drugs Type and Applications
Table Eli Lilly Gynecology Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Gynecology Drugs Type and Applications
Table AstraZeneca Gynecology Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Gynecology Drugs Type and Applications
Table Allergan Gynecology Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Gynecology Drugs Type and Applications
Table Amgen Gynecology Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Chengdu Enwei Group Basic Information, Manufacturing Base and Competitors
Table Chengdu Enwei Group Gynecology Drugs Type and Applications
Table Chengdu Enwei Group Gynecology Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Global Gynecology Drugs Revenue (Million USD) by Players (2014-2019)
Table Global Gynecology Drugs Revenue Share by Players (2014-2019)
Figure Global Gynecology Drugs Revenue Share by Players in 2017
Figure Global Gynecology Drugs Revenue Share by Players in 2018
Figure Global Top 5 Players Gynecology Drugs Revenue Market Share in 2018
Figure Global Top 10 Players Gynecology Drugs Revenue Market Share in 2018
Figure Global Gynecology Drugs Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Gynecology Drugs Revenue (Million USD) by Regions (2014-2019)
Table Global Gynecology Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Gynecology Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Gynecology Drugs Revenue Market Share by Regions in 2018
Figure North America Gynecology Drugs Revenue and Growth Rate (2014-2019)
Figure Europe Gynecology Drugs Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Gynecology Drugs Revenue and Growth Rate (2014-2019)
Figure South America Gynecology Drugs Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Gynecology Drugs Revenue and Growth Rate (2014-2019)
Table North America Gynecology Drugs Revenue by Countries (2014-2019)
Table North America Gynecology Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Gynecology Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Gynecology Drugs Revenue Market Share by Countries in 2018
Figure USA Gynecology Drugs Revenue and Growth Rate (2014-2019)
Figure Canada Gynecology Drugs Revenue and Growth Rate (2014-2019)
Figure Mexico Gynecology Drugs Revenue and Growth Rate (2014-2019)
Table Europe Gynecology Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Europe Gynecology Drugs Revenue Market Share by Countries (2014-2019)
Figure Europe Gynecology Drugs Revenue Market Share by Countries in 2018
Figure Germany Gynecology Drugs Revenue and Growth Rate (2014-2019)
Figure UK Gynecology Drugs Revenue and Growth Rate (2014-2019)
Figure France Gynecology Drugs Revenue and Growth Rate (2014-2019)
Figure Russia Gynecology Drugs Revenue and Growth Rate (2014-2019)
Figure Italy Gynecology Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Gynecology Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Gynecology Drugs Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Gynecology Drugs Revenue Market Share by Countries in 2018
Figure China Gynecology Drugs Revenue and Growth Rate (2014-2019)
Figure Japan Gynecology Drugs Revenue and Growth Rate (2014-2019)
Figure Korea Gynecology Drugs Revenue and Growth Rate (2014-2019)
Figure India Gynecology Drugs Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Gynecology Drugs Revenue and Growth Rate (2014-2019)
Table South America Gynecology Drugs Revenue by Countries (2014-2019)
Table South America Gynecology Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Gynecology Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Gynecology Drugs Revenue Market Share by Countries in 2018
Figure Brazil Gynecology Drugs Revenue and Growth Rate (2014-2019)
Figure Argentina Gynecology Drugs Revenue and Growth Rate (2014-2019)
Figure Colombia Gynecology Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Gynecology Drugs Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Gynecology Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Gynecology Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Gynecology Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Gynecology Drugs Revenue and Growth Rate (2014-2019)
Figure UAE Gynecology Drugs Revenue and Growth Rate (2014-2019)
Figure Egypt Gynecology Drugs Revenue and Growth Rate (2014-2019)
Figure Nigeria Gynecology Drugs Revenue and Growth Rate (2014-2019)
Figure South Africa Gynecology Drugs Revenue and Growth Rate (2014-2019)
Table Global Gynecology Drugs Revenue (Million USD) by Type (2014-2019)
Table Global Gynecology Drugs Revenue Share by Type (2014-2019)
Figure Global Gynecology Drugs Revenue Share by Type (2014-2019)
Figure Global Gynecology Drugs Revenue Share by Type in 2019
Table Global Gynecology Drugs Revenue Forecast by Type (2019-2024)
Figure Global Gynecology Drugs Market Share Forecast by Type (2019-2024)
Figure Global Hormonal Therapy Revenue Growth Rate (2014-2019)
Figure Global Non-hormonal Therapy Revenue Growth Rate (2014-2019)
Table Global Gynecology Drugs Revenue by Application (2014-2019)
Table Global Gynecology Drugs Revenue Share by Application (2014-2019)
Figure Global Gynecology Drugs Revenue Share by Application (2014-2019)
Figure Global Gynecology Drugs Revenue Share by Application in 2019
Table Global Gynecology Drugs Revenue Forecast by Application (2019-2024)
Figure Global Gynecology Drugs Market Share Forecast by Application (2019-2024)
Figure Global Hospital Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Retail Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Online Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Gynecology Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Gynecology Drugs Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Gynecology Drugs Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Gynecology Drugs Revenue Market Forecast (2019-2024)
Figure Europe Gynecology Drugs Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Gynecology Drugs Revenue Market Forecast (2019-2024)
Figure South America Gynecology Drugs Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Gynecology Drugs Revenue Market Forecast (2019-2024)


【掲載企業】

Pfizer、Roche、AbbVie、Bayer、Merck、Abbott Laboratories、GlaxoSmithKline、Johnson & Johnson、Sanofi、Novartis、Eli Lilly、AstraZeneca、Allergan、Amgen、Chengdu Enwei Group、

★調査レポート[婦人科薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9103384)販売に関する免責事項を必ずご確認ください。
★調査レポート[婦人科薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 産婦人科ストレッチャーの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103393 / GlobalInfoResearch / 2019年9月26日 / 本調査レポートは、産婦人科ストレッチャーの世界市場について調べ、まとめました。種類別セグメントは、固定ストレッチャー、調整可能なストレッチャー、ストレッチャーチェアー等、用途別セグメントは、病院、診療所および救急車施設等に区分しました。産婦人科ストレッチャーの世界市場概観、メーカー動向、メーカー別産婦人科ストレッチャーシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・産婦人科ストレッチャーの市場概観 ・産婦人科ストレッチャーの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・産婦人科ストレッチャーの企業別販売動向、市場シェア、市場集中度、競争動向 ・産婦人科ストレッチャーの世界市場規模 ・産婦人科ストレッチャーの北米市場分析（アメリカ、カナダ、メキシコ等） ・産婦人科ストレッチャーのアメリカ市場規模推移 ・産婦人科ストレッチャーのカナダ市場規模推移 ・産婦人科ストレッチャーのメキシコ市場規模推移 ・産婦人科ストレッチャーのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Today's medical stretchers serve a vital purpose in the health care field: to safely and securely convey injured patients through hospitals, private practices, and clinics. Hospital stretchers are also used by emergency medical technicians to transport the critically injured into emergency rooms. Patients undergoing operative procedures are brought from operating rooms into recovery areas on transport stretchers. Obstetrics and Gynecology Stretchers are the stretchers used for obstetrics and gynecology. Scope of the Report: The worldwide market for Obstetrics and Gynecology Stretchers is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$...
  • OB / GYN（産婦人科）ストレッチャーの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103395 / GlobalInfoResearch / 2019年9月26日 / 本調査レポートは、OB / GYN（産婦人科）ストレッチャーの世界市場について調べ、まとめました。種類別セグメントは、固定ストレッチャー、調整可能なストレッチャー、ストレッチャーチェアー等、用途別セグメントは、病院、診療所および救急車施設等に区分しました。OB / GYN（産婦人科）ストレッチャーの世界市場概観、メーカー動向、メーカー別OB / GYN（産婦人科）ストレッチャーシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・OB / GYN（産婦人科）ストレッチャーの市場概観...Today's medical stretchers serve a vital purpose in the health care field: to safely and securely convey injured patients through hospitals, private practices, and clinics. Hospital stretchers are also used by emergency medical technicians to transport the critically injured into emergency rooms. Patients undergoing operative procedures are brought from operating rooms into recovery areas on transport stretchers. Obstetrics and Gynecology Stretchers are the stretchers used for obstetrics and gynecology. Scope of the Report: The worldwide market for OB/GYN (Obstetrics and Gynecology) Stretchers is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million...
  • 神経芽腫薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102908 / GlobalInfoResearch / 2019年9月23日 / 本調査レポートは、神経芽腫薬の世界市場について調べ、まとめました。種類別セグメントは、化学療法、免疫療法、その他等、用途別セグメントは、病院、診療所、その他等に区分しました。神経芽腫薬の世界市場概観、企業動向、企業別神経芽腫薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・神経芽腫薬の市場概観 ・神経芽腫薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・神経芽腫薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・神経芽腫薬の世界市場規模 ・神経芽腫薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・神経芽腫薬のアメリカ市場規模推移 ・神経芽腫薬のカナダ市場規模推移 ・神経芽腫薬のメキシコ市場規模推移 ・神経芽腫薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Neuroblastoma (NB) is a type of cancer that forms in certain types of nerve tissue. It most frequently starts from one of the adrenal glands, but can also develop in the neck, chest, abdomen, or spine. Symptoms may include bone pain, a lump in the abdomen, neck, or chest, or a painless bluish lump under the skin. Scope of the Report: The global Neuroblastoma Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will...
  • 全身麻酔薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101944 / GlobalInfoResearch / 2019年9月16日 / 本調査レポートは、全身麻酔薬の世界市場について調べ、まとめました。種類別セグメントは、プロポフォール、セボフルラン、イソフルラン、デクスメデトミジン、デスフルラン、レミフェンタニル、ミダゾラム、その他等、用途別セグメントは、病院、診療所、その他等に区分しました。全身麻酔薬の世界市場概観、企業動向、企業別全身麻酔薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・全身麻酔薬の市場概観 ・全身麻酔薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・全身麻酔薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・全身麻酔薬の世界市場規模 ・全身麻酔薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・全身麻酔薬のアメリカ市場規模推移 ・全身麻酔薬のカナダ市場規模推移 ・全身麻酔薬のメキシコ市場規模推移 ・全身麻酔薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...General Anaesthesia Drugs act on the central nervous system, inducing a sedative state in patients who are to go through a surgical procedure. Scope of the Report: The global General Anaesthesia Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot...
  • 咳止め薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103572 / GlobalInfoResearch / 2019年9月27日 / 本調査レポートは、咳止め薬の世界市場について調べ、まとめました。種類別セグメントは、乾いた咳、湿った咳等、用途別セグメントは、病院、小売薬局、オンライン薬局、その他等に区分しました。咳止め薬の世界市場概観、企業動向、企業別咳止め薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・咳止め薬の市場概観 ・咳止め薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・咳止め薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・咳止め薬の世界市場規模 ・咳止め薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・咳止め薬のアメリカ市場規模推移 ・咳止め薬のカナダ市場規模推移 ・咳止め薬のメキシコ市場規模推移 ・咳止め薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Cough Suppressant, also known as cAntitussives, are widely used to relieve the symptoms of cough. They are substances which suppress the coughing itself. Examples are codeine, pholcodine, dextromethorphan, noscapine, and butamirate. Scope of the Report: The global Cough Suppressant Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States,...

    • ◆H&Iグローバルリサーチのお客様（例）◆